Senior Pharmacovigilance Lead – Hybrid & Bonus

STADA Arzneimittel AG; Greater London; Hybrid; GBP 40,000 - 60,000; Full time

Job summary

A leading pharmaceutical company in the UK is seeking a Senior PV Officer to ensure compliance with MHRA/EU regulations and enhance pharmacovigilance. The ideal candidate will have proven experience in the pharmaceutical industry, excellent communication and organizational skills, and the ability to work with cross-functional teams. This role offers a competitive salary, a hybrid working model, and various employee benefits aimed at improving your quality of life and professional development.

Benefits

Competitive salary and annual bonus scheme

Salary Sacrifice Pension Scheme with 6% contribution

Hybrid working model

25 days annual leave plus bank holidays

Wellbeing support through Employee Assistance Programme

Electric Car Scheme

Enhanced Family Leave

Qualifications

• Proven experience in the pharmaceutical or biotechnology industry.
• Ability to communicate effectively with stakeholders.
• Experience in compliance with MHRA/EU regulations.

Responsibilities

• Liaise for MHRA and STADA PV matters.
• Develop and update SOPs for regulatory requirements.
• Manage regulatory activities including safety updates.
• Play a role in audits and compliance activities.
• Mentor and train team members in PV regulations.

Skills

Multi-channel communication skills

Organisational skills

Interpersonal skills

Problem-solving approach

Attention to detail

Proficiency in MS Office

Job description

A leading pharmaceutical company in the UK is seeking a Senior PV Officer to ensure compliance with MHRA/EU regulations and enhance pharmacovigilance. The ideal candidate will have proven experience in the pharmaceutical industry, excellent communication and organizational skills, and the ability to work with cross-functional teams. This role offers a competitive salary, a hybrid working model, and various employee benefits aimed at improving your quality of life and professional development.